Patents by Inventor John Feild

John Feild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bovine aggrecanase-1
    Publication number: 20020160492
    Abstract: Bovine aggrecanase-1 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds that either agonize or antagonize bovine aggrecanase-1. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: osteoarthritis, rheumatoid arthritis, joint injury, reactive and psoriatic arthritis and other diseases of bone.
    Type: Application
    Filed: July 25, 2001
    Publication date: October 31, 2002
    Inventors: Michael N. Cook, John Feild
  • Polynucleotide and polypeptide sequences encoding murine organic anion transporter 5 (mOATP5)
    Patent number: 6420544
    Abstract: Mouse OATP5 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds which either agonize or antagonize mouse OATP5. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: cancer, inflammation, cardiovascular disease, central nervous system disorders, auto-immune disease, and kidney and liver disease.
    Type: Grant
    Filed: May 17, 2000
    Date of Patent: July 16, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Harma Ellens, John Feild, Lin Yue
  • Human sodium dependent phosphate transporter (IPT-1)
    Patent number: 6350858
    Abstract: IPT-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IPT-1 polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, end stage renal disease, uremic bone disease, and cancer, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: April 19, 2000
    Date of Patent: February 26, 2002
    Assignee: SmithKline Beecham Corporation
    Inventor: John Feild
  • Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
    Patent number: 6319688
    Abstract: IPT-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IPT-1 polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, end stage renal disease, uremic bone disease, and cancer, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: November 20, 2001
    Assignee: SmithKline Beecham Corporation
    Inventor: John Feild